Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Oct 21, 2024

BUY
$5.62 - $11.51 $64,281 - $131,651
11,438 New
11,438 $66,000
Q1 2023

May 03, 2023

BUY
$5.62 - $11.51 $64,281 - $131,651
11,438 New
11,438 $66,000
Q3 2022

Nov 07, 2022

BUY
$3.09 - $9.21 $72,306 - $215,514
23,400 New
23,400 $74,000

Others Institutions Holding ICVX

About Icosavax, Inc.


  • Ticker ICVX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,885,200
  • Description
  • Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company, with the help of its virus-like particle (VLP) platform technology, focuses primarily on life-threatening respiratory diseases. Its products in pipeline include IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical tri...
More about ICVX
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.